Level of xerostomia in patients with diabetes mellitus type II
DOI:
https://doi.org/10.35381/s.v.v8i1.3716Keywords:
Diabetes mellitus, diabetes mellitus type 1, diet diabetic, (Source: DeCS)Abstract
Objective: to analyze the level of xerostomia in patients with type II diabetes mellitus. Methods: Descriptive observational study. Results and conclusion: Through statistical analysis and interpretation of the data obtained in the present investigation through the cotton test, it is concluded that the level of xerostomia in patients with diabetes mellitus type II in the diabetic club of the Health Center N°1 of Ibarra, with less than five years of treatment have low levels of salivation compared to patients with more than five years of treatment; The patients with less time of medication showed an average of 2.267 ml/min and the patients with more time of medication had an average of 1.753 ml/min, for this reason it was determined that the longer the treatment time the higher the level of xerostomia in the mouth.
Downloads
References
Padhi S, Nayak AK, Behera A. Type II diabetes mellitus: a review on recent drug based therapeutics. Biomed Pharmacother. 2020;131:110708. http://dx.doi.org/10.1016/j.biopha.2020.110708
Naz R, Saqib F, Awadallah S, et al. Food Polyphenols and Type II Diabetes Mellitus: Pharmacology and Mechanisms. Molecules. 2023;28(10):3996. 10. http://dx.doi.org/10.3390/molecules28103996
Narasimhan A, Flores RR, Robbins PD, Niedernhofer LJ. Role of Cellular Senescence in Type II Diabetes. Endocrinology. 2021;162(10):bqab136. http://dx.doi.org/10.1210/endocr/bqab136
Mukhtar MH, Nasif WA, Alnashri YA, et al. The Detrimental Effect of Type II Diabetes Mellitus on Infected Patients with COVID-19. Clin Lab. 2023;70(04). http://dx.doi.org/10.7754/Clin.Lab.2023.230541
Shen S, Wang F, Fernandez A, Hu W. Role of platelet-derived growth factor in type II diabetes mellitus and its complications. Diab Vasc Dis Res. 2020;17(7):1479164120942119. http://dx.doi.org/10.1177/1479164120942119
Pathak LA, Ruparelia RV, Bhadiadra KK. Risk Stratification for Asymptomatic Coronary Artery Disease in patients with Type II Diabetes Mellitus. J Assoc Physicians India. 2021;69(11):11-12.
Russel SM, Valle V, Spagni G, et al. Physiologic Mechanisms of Type II Diabetes Mellitus Remission Following Bariatric Surgery: a Meta-analysis and Clinical Implications. J Gastrointest Surg. 2020;24(3):728-741. http://dx.doi.org/10.1007/s11605-019-04508-2
Massimino E, Izzo A, Riccardi G, Della Pepa G. The Impact of Glucose-Lowering Drugs on Sarcopenia in Type 2 Diabetes: Current Evidence and Underlying Mechanisms. Cells. 2021;10(8):1958. http://dx.doi.org/10.3390/cells10081958
Dreyer NS, Lynggaard CD, Jakobsen KK, Pedersen AML, von Buchwald C, Grønhøj C. Ugeskr Laeger. 2021;183(27):V11200814.
Rohani B. Oral manifestations in patients with diabetes mellitus. World J Diabetes. 2019;10(9):485-489. http://dx.doi.org/10.4239/wjd.v10.i9.485
López Pintor RM, Casañas E, González Serrano J, et al. Xerostomia, Hyposalivation, and Salivary Flow in Diabetes Patients. J Diabetes Res. 2016;2016:4372852. http://dx.doi.org/10.1155/2016/4372852
Dodds MW, Dodds AP. Effects of glycemic control on saliva flow rates and protein composition in non-insulin-dependent diabetes mellitus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997;83(4):465-470. http://dx.doi.org/10.1016/s1079-2104(97)90147-5
Forbat LN, Collins RE, Maskell GK, Sönksen PH. Glucose concentrations in parotid fluid and venous blood of patients attending a diabetic clinic. J R Soc Med. 1981;74(10):725-728. http://dx.doi.org/10.1177/014107688107401004
Reuterving CO, Reuterving G, Hägg E, Ericson T. Salivary flow rate and salivary glucose concentration in patients with diabetes mellitus influence of severity of diabetes. Diabete Metab. 1987;13(4):457-462.
Hoseini A, Mirzapour A, Bijani A, Shirzad A. Salivary flow rate and xerostomia in patients with type I and II diabetes mellitus. Electron Physician. 2017;9(9):5244-5249. http://dx.doi.org/10.19082/5244
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Leslye Dayann Cuaspud-Estrada, Jean Jared Valencia-Guerrero, Dahli Alejandra Vásquez-Ipial, Pablo Danilo Jurado-Carrera
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
CC BY-NC-SA : Esta licencia permite a los reutilizadores distribuir, remezclar, adaptar y construir sobre el material en cualquier medio o formato solo con fines no comerciales, y solo siempre y cuando se dé la atribución al creador. Si remezcla, adapta o construye sobre el material, debe licenciar el material modificado bajo términos idénticos.
OAI-PMH: https://fundacionkoinonia.com.ve/ojs/index.php/saludyvida/oai.
